Skip to content

Capital BlueCross

Does Capital BlueCross cover Zepbound for Weight Loss?

Yes. Capital BlueCross covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.

Policy document

  • Capital BlueCross Employer / Commercial Insurance prior authorization policy

    Capital BlueCross · PA policy · Employer

    Effective May 18, 2026. Verified June 5, 2026.

    View PDF Download Original insurer source
  • Employer: Covered with requirements. See the qualification pathways below.

Earliest policy review June 5, 2026. How we verify · Check your exact plan

Full requirements: Zepbound for Weight Loss (1 plan type)

Applies to Employer plans.

Covered with requirements

Qualification pathways

You can qualify through any one of these.

Adult obesity

All of:

  • Age ≥ 18 years
  • BMI ≥ 30 kg/m2

Adult overweight with comorbidity

All of:

  • Age ≥ 18 years
  • BMI ≥ 27 kg/m2

Plus any one of:

  • Hypertension
  • Type 2 diabetes
  • Dyslipidemia
  • OSA
  • CVD
  • MASH

Asian adult obesity/overweight

All of:

  • South Asian, Southeast Asian, or East Asian ethnicity
  • BMI ≥ 23 kg/m2

Documentation to bring

  • BMI documentation meeting threshold (≥ 30 kg/m2 for obesity, or ≥ 27 kg/m2 for overweight with comorbidity)
  • Documentation of weight-related comorbidity if BMI 27-29.9 kg/m2
  • For continuation: documentation of ≥ 5% weight loss after 12 weeks at therapeutic dose

Approval and renewal

  • Renewal: At least 5% weight loss after 12 weeks at a therapeutic dose is required for continuation.
  • Renewal: At least 12 weeks on therapy before the first renewal.

Not covered when

  • Coadministration with other tirzepatide-containing products or with any GLP-1 receptor agonist is not recommended

Policy note: Available as subcutaneous injection solution (vial) and Kwikpen formulations. Indicated for adults only (age ≥ 18) for weight loss. The Asian BMI threshold of ≥ 23 kg/m2 is noted in the clinical rationale for South Asian, Southeast Asian, and East Asian adults. Efficacy should be assessed after 12 weeks at a therapeutic dose; continuation recommended only for patients achieving ≥ 5% weight loss.

Policy effective May 18, 2026 · verified June 5, 2026 · source: Capital BlueCross Employer / Commercial Insurance prior authorization policy · View policy document (PDF)

Open on its own page →

Questions people ask
Does Capital BlueCross cover Zepbound?
Yes. Capital BlueCross covers Zepbound for weight loss with prior authorization if your BMI is 30 or higher, or 27 or higher with a related condition. Other policy requirements and your plan's benefits also apply.
What does Capital BlueCross require to renew Zepbound?
Weight Loss — Applies to Employer plans. At least 5% weight loss after 12 weeks at a therapeutic dose is required for continuation. At least 12 weeks on therapy before the first renewal.
How current is this information?
The oldest review date among the policies on this page is June 5, 2026. Each policy's effective and verification dates appear with its requirements. Confirm current benefits with your plan.

Also under Capital BlueCross: Mounjaro, Ozempic, Wegovy

Zepbound under other plans: Highmark, Pennsylvania Medicaid, BCBS Alabama, BCBS Arizona, BCBS Arkansas, BCBS Massachusetts, BCBS Michigan, BCBS Minnesota

All insurance plans · All medications

Summary of Capital BlueCross's written policy, not a guarantee of coverage. Plans vary by employer and benefit design.